Japanese Scientists Introduce New HIV Drug

	Tweet

Japanese researchers have developed a durable new drug that blocks HIV from entering human cells and causes almost no side effects.

The new drug, code named AK602, was unveiled by Hiroaki Mitsuya, leader of the research team at Kumamoto University, at the International Congress on AIDS in Asia and the Pacific in Kobe Tuesday, the Asahi Shimbun reported Wednesday.

The drug’s main feature is that it shuts out the AIDS virus at the point when it tries to intrude into a human cell.

Current AIDS medications often lose their effectiveness after a few days due to the virus’ resistance, but the AK602 reacts to human cells instead of attacking the virus, said Mitsuya, a university professor.

When the new drug becomes attached to the protein that acts as an entrance into human cells for the AIDS virus, it can prevent HIV from entering.

The researchers conducted clinical tests on 40 AIDS patients in the United States. When the patients took 0.02 ounces of AK602 twice a day for 10 days, the number of HIV viruses dropped to an average of 1 percent.

Almost no side effects were reported, the professor said.

Source: United Press International

RELATED STORIES:
FDA Advisory Panel Approves Home HIV Test Kit   FDA Approves New In-Home HIV Test   Home HIV test advances   Survey Reveals Support for Over-the Counter HIV Testing   F.D.A. Panel Weighs Preventive Use of H.I.V. Drug   Stem Cell Therapy Shows Promise in Fight Against HIV   Progress against HIV thwarted by patients’ unmet needs   California to test pill for HIV prevention   Mechanism of HIV spread has potential for future drug therapy   Seeking HIV treatment clues in the neem tree   HIV Prevention Pill’s Value Varies by Target   Using AIDS drugs to prevent infection: a bargain?

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]